YU93002A - 5-(4-(2-(n-metil-n-(2-piridil)amino)etoksi)benzil)tiazolidin-2,4-dion hidrojodid kao farmaceutski preparat - Google Patents

5-(4-(2-(n-metil-n-(2-piridil)amino)etoksi)benzil)tiazolidin-2,4-dion hidrojodid kao farmaceutski preparat

Info

Publication number
YU93002A
YU93002A YU93002A YUP93002A YU93002A YU 93002 A YU93002 A YU 93002A YU 93002 A YU93002 A YU 93002A YU P93002 A YUP93002 A YU P93002A YU 93002 A YU93002 A YU 93002A
Authority
YU
Yugoslavia
Prior art keywords
thiazolidine
pyridyl
ethoxy
benzyl
amino
Prior art date
Application number
YU93002A
Other languages
English (en)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Michael John Millan
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of YU93002A publication Critical patent/YU93002A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Novo farmaceutsko jedinjenje 5-[4-[2-(N-metil-N-(2-piridil)amino)etoksi)]benzil] tiazolidin-2,4-dion hidrojodid ili njegov solvat, postupak dobijanja takvog jedinjenja, farmaceutski preparat koji sadrži takvo jedinjenje i upotreba takvog jedinjenja u medicini.[A novel pharmaceutical compound 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione hydriodide or a solvate thereof, a process for preparing such a compound, a pharmaceutical composition comprising such a compound and the use of such a compound in medicine.
YU93002A 2000-06-08 2001-06-08 5-(4-(2-(n-metil-n-(2-piridil)amino)etoksi)benzil)tiazolidin-2,4-dion hidrojodid kao farmaceutski preparat YU93002A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0014005.3A GB0014005D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
YU93002A true YU93002A (sh) 2006-01-16

Family

ID=9893256

Family Applications (1)

Application Number Title Priority Date Filing Date
YU93002A YU93002A (sh) 2000-06-08 2001-06-08 5-(4-(2-(n-metil-n-(2-piridil)amino)etoksi)benzil)tiazolidin-2,4-dion hidrojodid kao farmaceutski preparat

Country Status (26)

Country Link
US (1) US20040024027A1 (sh)
EP (1) EP1292595A1 (sh)
JP (1) JP2003535861A (sh)
KR (1) KR20030007919A (sh)
CN (1) CN1443185A (sh)
AP (1) AP2002002684A0 (sh)
AU (2) AU2001262550B2 (sh)
BG (1) BG107356A (sh)
BR (1) BR0111508A (sh)
CA (1) CA2411064A1 (sh)
CZ (1) CZ20024029A3 (sh)
DZ (1) DZ3383A1 (sh)
EA (1) EA004298B1 (sh)
GB (1) GB0014005D0 (sh)
HU (1) HUP0301799A3 (sh)
IL (1) IL153280A0 (sh)
MA (1) MA26912A1 (sh)
MX (1) MXPA02012173A (sh)
NO (1) NO20025882L (sh)
NZ (1) NZ522997A (sh)
OA (1) OA12283A (sh)
PL (1) PL363683A1 (sh)
SK (1) SK17152002A3 (sh)
WO (1) WO2001094343A1 (sh)
YU (1) YU93002A (sh)
ZA (1) ZA200300017B (sh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
EA004298B1 (ru) 2004-02-26
BG107356A (bg) 2003-06-30
SK17152002A3 (sk) 2003-05-02
JP2003535861A (ja) 2003-12-02
PL363683A1 (en) 2004-11-29
IL153280A0 (en) 2003-07-06
HUP0301799A2 (hu) 2003-12-29
GB0014005D0 (en) 2000-08-02
AP2002002684A0 (en) 2002-12-31
OA12283A (en) 2003-11-10
AU6255001A (en) 2001-12-17
NO20025882D0 (no) 2002-12-06
BR0111508A (pt) 2003-03-25
EP1292595A1 (en) 2003-03-19
AU2001262550B2 (en) 2004-04-22
ZA200300017B (en) 2004-04-08
CA2411064A1 (en) 2001-12-13
DZ3383A1 (fr) 2001-12-13
EA200300004A1 (ru) 2003-04-24
HUP0301799A3 (en) 2005-04-28
MXPA02012173A (es) 2003-04-25
NO20025882L (no) 2003-01-29
KR20030007919A (ko) 2003-01-23
CN1443185A (zh) 2003-09-17
US20040024027A1 (en) 2004-02-05
WO2001094343A1 (en) 2001-12-13
MA26912A1 (fr) 2004-12-20
CZ20024029A3 (cs) 2003-04-16
NZ522997A (en) 2004-05-28

Similar Documents

Publication Publication Date Title
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
AP1715A (en) The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
DK1349855T3 (da) 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin-2,4-dionmesylatsalt
AP1814A (en) Tartrate salts of thiazolidinedione derivative.
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
AU2002343052A1 (en) Rosiglitazone edisylates and their use as antidiabetics
MXPA02012100A (es) Sal de tiazodilindiona para el tratamiento de la diabetes mellitus.
HK1057204A1 (en) A thiazolidinedione derivative and its use as antidiabetic
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
AP2003002737A0 (en) Tartrate salts of thiazolidinedione derivatives
AP1841A (en) A thiazolidinedione derivative and its use as antidiabetic.
HK1068884A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt
AP1738A (en) Sodium salts of 5-[4-[2-(N-Methyl -N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
AP1813A (en) Tartrate salts of thiazolidinedione derivative.